A receptor helps keep muscle stem cells unspecialized in mice
Mouse experiments found that steroid drugs’ effects on muscle repair were largely independent of the receptor in muscle stem cells.
Our read
Mechanisms- Studied:
- Preprint: experiments in mice
- In the record:
- One of 64 papers on dexamethasone on record: 13 with results in people, 17 in animals.
- Why it’s aging research:
- It studies organisms or tissues that aged naturally.
Editor of record: Boris Djordjevic · AgingResearch.News
Young and aged mice underwent experiments on a steroid hormone receptor in satellite cells, the stem cells that help repair muscle. Deleting the receptor reduced the number of cells carrying a stem cell marker during regeneration in young mice, but did not substantially impair repair at either age. Gene activity analyses supported a role for the receptor in keeping resting stem cells from committing to become muscle cells.
Chronic treatment with the steroid drug prednisone changed gene activity in regenerating muscle differently with age, without substantially affecting tissue repair. Another steroid drug, dexamethasone, given during the early inflammatory phase, delayed regeneration. Dead tissue persisted, and more collagen, a structural protein, accumulated. The drugs’ effects on repair were comparable in mice with and without the receptor in satellite cells.
Why it matters
Muscle stem cells support tissue repair. Studying their hormone responses in aged mice addresses how that repair is regulated later in life.
Caveats
The muscle-repair results came from mice and do not establish how these drugs affect repair in people. The work is a preprint and has not been peer-reviewed.
Where the evidence stands
Prednisone
- 8 independent labs in 6 countries
- 1,260 trials, 348 with no results posted
- Funders: National Institute of Diabetes and Digestive and Kidney Diseases and others
Dexamethasone
- 35 independent labs in 16 countries
- 4 findings against
- 2,158 trials, 613 with no results posted
- Funders: National Institutes of Health and others
- 1 of 76 findings with company ties
- 82 of 2,158 trials sponsored by its developers
The paper
Igbmc
bioRxiv, Nov 6, 2026, Open access, Preprint, not yet peer-reviewed

Comments
Be the first to comment.